Postoperative Pain Management

Introduction to Postoperative Pain Management

The American College of Obstetricians and Gynecologists, American College of Cardiology Foundation, and American Heart Association provide guidelines for postoperative pain management, recommending a stepped-care approach starting with acetaminophen, small doses of narcotics, or nonacetylated salicylates before considering NSAIDs, to minimize the risk of adverse effects from overlapping NSAID use 1, 2

Ketorolac (Toradol) is a nonsteroidal anti-inflammatory drug (NSAID) used for pain management, as recommended by the American Academy of Family Physicians and the National Comprehensive Cancer Network, with a recommended dose of 60mg intramuscularly every 15-30 minutes, not exceeding 120mg per day 3, 4, 5
The oral ibuprofen equivalent of 30mg IV ketorolac every 6 hours is approximately 800mg oral ibuprofen every 6 hours, based on comparative analgesic efficacy studies and clinical guidelines for postoperative pain management 4
The maximum safe dose of ketorolac is 120 mg per day, with treatment not to exceed 5 days total duration, as recommended by the American Academy of Family Physicians 3

Ketorolac is contraindicated in patients with:
Particular caution is needed when using ketorolac in high-risk populations, such as:

For elderly patients, renally impaired patients, or patients with low body weight, consider reducing the dose to 10 mg PO once, followed by 10 mg every 4-6 hours as needed, not exceeding 40 mg/day, as guided by the American Academy of Family Physicians 3
For these high-risk populations, consider reducing the ibuprofen dose to 600mg q6h, as part of general guidelines for postoperative pain management 4

Baseline assessment of blood pressure, BUN and creatinine, liver function tests, and CBC and fecal occult blood is recommended, with repeat tests every 3 months during long-term therapy, as suggested by the National Comprehensive Cancer Network 5
Discontinue ketorolac immediately if:

Acetaminophen 1000mg IV/PO can be used as an alternative to ketorolac when contraindicated, as recommended by the American College of Cardiology Foundation/American Heart Association guidelines 1
Small doses of opioids can be used for breakthrough pain when ketorolac is contraindicated, according to the American College of Cardiology guidelines 1
Non-pharmacological pain management techniques can be considered as an alternative to ketorolac when contraindicated, to minimize the risk of adverse effects from overlapping NSAID use 1

Concurrent NSAID administration increases the risk of gastrointestinal bleeding and perforation, renal impairment, platelet inhibition with altered hemostasis, and cardiovascular events, particularly in patients with underlying cardiovascular disease, as stated in the American College of Cardiology guidelines 1
If less than 4-6 hours have passed since ibuprofen administration, ketorolac administration should be avoided to prevent increased risk of adverse effects, according to the American College of Cardiology guidelines 1
If more than 6 hours have passed since ibuprofen administration, it is safe to administer ketorolac, as the risk of adverse effects from overlapping NSAID use is reduced 1